VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2020 | Revisiting farnesyltransferase inhibitors for head and neck cancer

Jared Weiss, MD, of UNC Lineberger, Chapel Hill, NC, discusses the use of tipifarnib, a farnesyltransferase inhibitor, in HRAS mutated head and neck cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter